190 related articles for article (PubMed ID: 19038343)
1. The role of chemokines in cancer immune surveillance by the adaptive immune system.
Krieg C; Boyman O
Semin Cancer Biol; 2009 Apr; 19(2):76-83. PubMed ID: 19038343
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted roles of chemokines in malignancy.
Ben-Baruch A
Cancer Metastasis Rev; 2006 Sep; 25(3):357-71. PubMed ID: 17016763
[TBL] [Abstract][Full Text] [Related]
3. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.
O'Hayre M; Salanga CL; Handel TM; Allen SJ
Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271
[TBL] [Abstract][Full Text] [Related]
5. [The role of plasma chemokines in cancer].
Struyf S; Van Damme J
Verh K Acad Geneeskd Belg; 2007; 69(3):149-65. PubMed ID: 17580816
[TBL] [Abstract][Full Text] [Related]
6. The role of CXC chemokines and their receptors in cancer.
Vandercappellen J; Van Damme J; Struyf S
Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
Ben-Baruch A
Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
[TBL] [Abstract][Full Text] [Related]
8. Natural immunity to cancer in humans.
Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J
Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124
[TBL] [Abstract][Full Text] [Related]
9. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.
Mishra P; Banerjee D; Ben-Baruch A
J Leukoc Biol; 2011 Jan; 89(1):31-9. PubMed ID: 20628066
[TBL] [Abstract][Full Text] [Related]
10. Chemokines in neuroectodermal tumour progression and metastasis.
Raffaghello L; Cocco C; Corrias MV; Airoldi I; Pistoia V
Semin Cancer Biol; 2009 Apr; 19(2):97-102. PubMed ID: 19013246
[TBL] [Abstract][Full Text] [Related]
11. The pros and cons of chemokines in tumor immunology.
Viola A; Sarukhan A; Bronte V; Molon B
Trends Immunol; 2012 Oct; 33(10):496-504. PubMed ID: 22726608
[TBL] [Abstract][Full Text] [Related]
12. T cells and their partners: The chemokine dating agency.
Viola A; Contento RL; Molon B
Trends Immunol; 2006 Sep; 27(9):421-7. PubMed ID: 16860609
[TBL] [Abstract][Full Text] [Related]
13. Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer?
Llera AS; Girotti MR; Benedetti LG; Podhajcer OL
Cytokine Growth Factor Rev; 2010 Feb; 21(1):67-76. PubMed ID: 20006533
[TBL] [Abstract][Full Text] [Related]
14. Escape from immune- and nonimmune-mediated tumor surveillance.
Malmberg KJ; Ljunggren HG
Semin Cancer Biol; 2006 Feb; 16(1):16-31. PubMed ID: 16140546
[TBL] [Abstract][Full Text] [Related]
15. The immune system--is it relevant to cancer development, progression and treatment?
Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory chemokines in cancer growth and progression.
Rollins BJ
Eur J Cancer; 2006 Apr; 42(6):760-7. PubMed ID: 16510278
[TBL] [Abstract][Full Text] [Related]
17. Cancer despite immunosurveillance: immunoselection and immunosubversion.
Zitvogel L; Tesniere A; Kroemer G
Nat Rev Immunol; 2006 Oct; 6(10):715-27. PubMed ID: 16977338
[TBL] [Abstract][Full Text] [Related]
18. Clinical utilization of chemokines to combat cancer: the double-edged sword.
Dell'Agnola C; Biragyn A
Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of chemokines in prostate cancer.
Vindrieux D; Escobar P; Lazennec G
Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
[TBL] [Abstract][Full Text] [Related]
20. Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotype.
Soria G; Meshel T; Ben-Baruch A
Methods Enzymol; 2009; 460():3-16. PubMed ID: 19446718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
